-
Archives
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- November 2010
- October 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
-
Meta
Tag Archives:
Agencia Española del Medicamento: Pioglitazona y Rosiglitazona
Agradecimiento a Martin Cañas. COMUNICACIÓN SOBRE RIESGOS DE MEDICAMENTOS PARA PROFESIONALES SANITARIOS Ref: 2007/13 19 de octubre de 2007 NOTA INFORMATIVA PIOGLITAZONA Y ROSIGLITAZONA: CONCLUSIONES DE LA EVALUACIÓN DEL BALANCE BENEFICIO-RIESGO EN EUROPA —————————— ————————————————– Como continuación de las notas … Continue reading
Posted in Diabetes Mellitus, tratamiento
Tagged , AGEMED, Diabetes Mellitus, Efectos Adversos, pioglitazona, rosiglitazona, tratamiento
1 Comment
GAPURMED/GAPURJovenes
